Log in to save to my catalogue

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: th...

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_24b4ea6d4fa847c2a2ca828386aa999b

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

About this item

Full title

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

Publisher

England: British Medical Journal Publishing Group

Journal title

BMJ open, 2021-02, Vol.11 (2), p.e045543-e045543

Language

English

Formats

Publication information

Publisher

England: British Medical Journal Publishing Group

More information

Scope and Contents

Contents

IntroductionMore than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) today will survive. However, half of the survivors are expected to experience therapy-related chronic or late occurring adverse effects, reducing quality of life. Insight into underlying risk trajectories is warranted. The aim of this study is to esta...

Alternative Titles

Full title

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_24b4ea6d4fa847c2a2ca828386aa999b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_24b4ea6d4fa847c2a2ca828386aa999b

Other Identifiers

ISSN

2044-6055

E-ISSN

2044-6055

DOI

10.1136/bmjopen-2020-045543

How to access this item